The Prevalence and Severity of Potential Drug–Drug Interactions in Internal Medicine Ward at Soba Teaching Hospital

References

• Makkaoui N, Halaoui A, Atoui Z, et al. Knowledge, attitudes, and practices regarding drug interactions among community pharmacists. J Public Heal. 2021;29(6):1357–1363. doi:10.1007/s10389-020-01252-9
   Google Scholar
• Tsui V, Thomas D, Tian S, et al. Adverse Drug Events, Medication Errors, and Drug Interactions. In: Clinical Pharmacy Education, Practice and Research. Elsevier; 2019:227–245.
   Google Scholar
• Gebretsadik Z, Gebrehans M, Getnet D, Gebrie D, Alema T, Belay YB. Assessment of drug-drug interaction in ayder comprehensive specialized Hospital, Mekelle, Northern Ethiopia: a Retrospective Study. Biomed Res Int. 2017;2017:9792363. doi:10.1155/2017/9792363
   PubMed Web of Science ®Google Scholar
• Snyder BD, Polasek TM, Doogue MP. Drug interactions: principles and practice. Aust Prescr. 2012;35(3):85–88. doi:10.18773/austprescr.2012.037
   Web of Science ®Google Scholar
• Zheng WY, Richardson LC, Li L, Day RO, Westbrook JI, Baysari MT. Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2018;74(1):15–27. doi:10.1007/s00228-017-2357-5
   PubMed Web of Science ®Google Scholar
• Shetty V, Chowta MN, Chowta KN, Shenoy A, Kamath A, Kamath P. Evaluation of potential drug-drug interactions with medications prescribed to geriatric patients in a tertiary care hospital. J Aging Res. 2018;2018:5728957. doi:10.1155/2018/5728957
   PubMedGoogle Scholar
• Georgiev KD, Hvarchanova N, Stoychev E, Kanazirev B. Prevalence of polypharmacy and risk of potential drug-drug interactions among hospitalized patients with emphasis on the pharmacokinetics. Sci Prog. 2022;105(1):003685042110701. doi:10.1177/00368504211070183
   Web of Science ®Google Scholar
• Korucu FC, Senyigit E, Köstek O, et al. A retrospective study on potential drug interactions: a single center experience. J Oncol Sci. 2018;4(2):80–84. doi:10.1016/j.jons.2018.06.001
   Google Scholar
• Murtaza G, Yasir M, Khan G, Azhar S, Ali S, Khan TM. Assessment of potential drug – drug interactions and its associated factors in the hospitalized cardiac patients. Saudi Pharm J. 2016;24(2):220–225. doi:10.1016/j.jsps.2015.03.009
   PubMed Web of Science ®Google Scholar
• Nusair MB, Al-azzam SI, Arabyat RM, Amawi HA, Alzoubi KH, Rabah AA. The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan. Saudi Pharm J. 2020;28(2):155–160. doi:10.1016/j.jsps.2019.11.009
   PubMed Web of Science ®Google Scholar
• Bhagavathula AS, Berhanie A, Tigistu H, et al. Prevalence of potential drug-drug interactions among internal medicine ward in University of Gondar Teaching Hospital, Ethiopia. Asian Pac J Trop Biomed. 2014;4(Suppl 1):S204–8. doi:10.12980/APJTB.4.2014C1172
   PubMedGoogle Scholar
• Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Drug-related problems in hospitals: a review of the recent literature. Drug Saf. 2007;30(5):379–407. doi:10.2165/00002018-200730050-00003
   PubMed Web of Science ®Google Scholar
• Vonbach P, Dubied A, Krähenbühl S, Beer JH. Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine. Eur J Intern Med. 2008;19(6):413–420. doi:10.1016/j.ejim.2007.12.002
   PubMed Web of Science ®Google Scholar
• Ismail M, Iqbal Z, Khattak MB, et al. Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan. Int J Clin Pharm. 2013;35(3):455–462. doi:10.1007/s11096-013-9764-1
   PubMed Web of Science ®Google Scholar
• Osman MA, Abdalla MA, Mohamed AA, Yousef BA. Assessment of drug–drug interactions between chemotherapeutic and chronically used medications at Khartoum oncology hospital. Matrix Sci Medica. 2020;4(3):79–84. doi:10.4103/MTSM.MTSM_17_20
   Google Scholar
• Hamadouk RM, Albashair ED, Mohammed FM, Yousef BA. The practice of the community pharmacists in managing potential drug-drug interactions: a simulated patient visits. Integr Pharm Res Pract. 2022;11:71–84. doi:10.2147/IPRP.S355675
   PubMed Web of Science ®Google Scholar
• Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):1623–1627. doi:10.1371/journal.pmed.0040296
   Web of Science ®Google Scholar
• Lexicomp® Drug Interact. Wolters Kluwer. Available from: https://online.lexi.com/loc/action/home. Accessed October 14, 2022.
   Google Scholar
• Van LRWF, Swart EL, Boven E, Boom FA, Schuitenmaker MG, Hugtenburg JG. Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method. Ann Oncol. 2011;22(10):2334–2341. doi:10.1093/annonc/mdq761
   PubMed Web of Science ®Google Scholar
• Abunahlah N, Elawaisi A, Velibeyoglu FM, Sancar M. Drug related problems identified by clinical pharmacist at the internal medicine Ward in Turkey. Int J Clin Pharm. 2018;40(2):360–367. doi:10.1007/s11096-017-0585-5
   PubMed Web of Science ®Google Scholar
• World Health Organization. Safety of Medicines: A Guide to Detecting and Reporting Adverse Drug Reactions: Why Health Professionals Need to Take Action. Geneva: World Health Organization; 2002.
   Google Scholar
• Teka F, Teklay G, Ayalew E, Teshome T. Potential drug-drug interactions among elderly patients admitted to medical ward of ayder referral hospital, Northern Ethiopia: a cross sectional study. BMC Res Notes. 2016;9(1):431. doi:10.1186/s13104-016-2238-5
   PubMedGoogle Scholar
• Mousavi S, Ghanbari G. Potential drug-drug interactions among hospitalized patients in a developing country. Casp J Intern Med. 2017;8(4):282–288.
   PubMedGoogle Scholar
• Kulkarni V, Bora SS, Sirisha S, Saji M, Sundaran S. A study on drug–drug interactions through prescription analysis in a South Indian teaching hospital. Ther Adv Drug Saf. 2013;4(4):141–146. doi:10.1177/2042098613490009
   PubMedGoogle Scholar
• Doubova SV, Reyes-Morales H, Torres-Arreola LDP, Suárez-Ortega M. Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City. BMC Health Serv Res. 2007;7(147). doi:10.1186/1472-6963-7-147
   Google Scholar
• Reimche L, Forster AJ, Van Walraven C. Incidence and contributors to potential drug-drug interactions in hospitalized patients. J Clin Pharmacol. 2011;51(7):1043–1050. doi:10.1177/0091270010378858
   PubMed Web of Science ®Google Scholar
• Sepehri G, Khazaelli P, Dahooie FA, Sepehri E, Dehghani MR. Prevalence of potential drug interactions in an Iranian general hospital. Indian J Pharm Sci. 2012;74(1):75–79. doi:10.4103/0250-474X.102548
   PubMed Web of Science ®Google Scholar
• Janchawee B, Wongpoowarak W, Owatranporn T, Chongsuvivatwong V. Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand. J Clin Pharm Ther. 2005;30(1):13–20. doi:10.1111/j.1365-2710.2004.00598.x
   PubMed Web of Science ®Google Scholar
• Moura C, Acurcio F, Belo N. Drug-drug interactions associated with length of stay and cost of hospitalization. J Pharm Pharm Sci. 2009;12(3):266–272. doi:10.18433/J35C7Z
   PubMed Web of Science ®Google Scholar
• Riechelmann RP, Tannock IF, Wang L, Saad ED, Taback NA, Krzyzanowska MK. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst. 2007;99(8):592–600. doi:10.1093/jnci/djk130
   PubMedGoogle Scholar
• Egger SS, Drewe J, Schlienger RG. Potential drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol. 2003;58(11):773–778. doi:10.1007/s00228-002-0557-z
   PubMed Web of Science ®Google Scholar
• Andersson ML, Böttiger Y, Kockum H, Eiermann B. High prevalence of drug–drug interactions in primary health care is caused by prescriptions from other healthcare units. Basic Clin Pharmacol Toxicol. 2018;122(5):512–516. doi:10.1111/bcpt.12939
   PubMed Web of Science ®Google Scholar
• Jazbar J, Locatelli I, Horvat N, Kos M. Clinically relevant potential drug–drug interactions among outpatients: a nationwide database study. Res Soc Adm Pharm. 2018;14(6):572–580. doi:10.1016/j.sapharm.2017.07.004
   PubMed Web of Science ®Google Scholar
• Dirin MM, Mousavi S, Afshari AR, Tabrizian K, Ashrafi MH. Potential drug ‑ drug interactions in prescriptions dispensed in community and hospital pharmacies in East of Iran. J Res Pharm Pract. 2014;3(3). doi:10.4103/2279-042X.141118
   PubMedGoogle Scholar
• Hasnain H, Ali H, Zafar F, et al. Drug-drug interaction; facts and comparisons with national and international bench marks. A threat more than a challenge for patient safety in clinical and economic scenario. Prof Med J. 2017;24(03):357–365.
   Google Scholar
• Riaz MK. Potential drug-drug interactions and strategies for their detection and prevention. Farmacia. 2019;67(4):572–579. doi:10.31925/farmacia.2019.4.3
   Web of Science ®Google Scholar
• Bojuwoye AO, Suleman F, Perumal-Pillay VA. Polypharmacy and the occurrence of potential drug–drug interactions among geriatric patients at the outpatient pharmacy department of a regional hospital in Durban, South Africa. J Pharm Policy Pract. 2022;15(1):1–12. doi:10.1186/s40545-021-00401-z
   PubMed Web of Science ®Google Scholar